Table 3. The clinical and biochemical characteristics of rs1799750 polymorphism among two groups.

	rs1799750 (case/control)			1G2G vs 1G1G	2G2G vs 1G1G	1G1G + 1G2G vs 2G2G	1G1G vs 1G2G + 2G2G
Variable	1G1G	1G2G	2G2G
Sex
Male	42/68	85/96	37/35	1.43 (0.89–2.32); 0.144	1.71 (0.94–3.12); 0.080	1.37 (0.81–2.29); 0.238	1.51 (0.96–2.38); 0.078
Female	34/71	69/105	39/26	1.37 (0.83–2.28); 0.223	3.13 (1.65–5.96); <0.001	2.56 (1.48–4.45); <0.001	1.72 (1.06–2.79); 0.027
Age
<55	55/92	103/133	55/43	1.29 (0.85–1.98); 0.229	2.14 (1.27–3.60); 0.004	1.82 (1.16–2.85); 0.009	1.50 (1.01–2.23); 0.045
≥55	21/47	51/68	21/18	1.68 (0.89–3.15); 0.107	2.61 (1.16–5.89); 0.020	1.86 (0.93–3.73); 0.079	1.87 (1.03–3.42); 0.041

Bold values are statistically significant (P<0.05).